Propranolol-induced changes in ventricular isomyosin composition in the rat.

Area of Science:

• Cardiovascular Physiology
• Molecular Cardiology
• Pharmacology

Background:

• Rat ventricular isomyosin comprises V1, V2, and V3 isoenzymes with varying Ca++-activated ATPase activity.
• These isoenzymes influence myocardial contractility and economy.
• Propranolol is a beta-blocker with known effects on cardiac function.

Purpose of the Study:

• To investigate the impact of chronic propranolol administration on rat ventricular isomyosin composition.
• To correlate changes in isomyosin profile with functional cardiac parameters.

Main Methods:

• Wistar rats were treated with propranolol (10 mg/kg/day) or placebo from 4 to 12 weeks of age.
• Beta-blockade efficacy was confirmed via isoproterenol test.
• Left ventricular myosin was purified, Ca++-activated ATPase activity was measured, and isomyosin composition was analyzed using gel electrophoresis.

Main Results:

• Propranolol treatment significantly reduced heart rate.
• No significant differences were observed in blood pressure, body weight, or ventricular weight.
• Propranolol-treated rats exhibited lower Ca++-activated ATPase activity and increased expression of V2 and V3 myosin isoenzymes.

Conclusions:

• Chronic propranolol administration induces a shift in ventricular isomyosin composition towards V2 and V3 isoenzymes in rats.
• This alteration in myosin profile may underlie observed changes in myocardial contractility and oxygen consumption.
• Further research is needed to establish the precise relationship between isomyosin shifts and functional cardiac modifications induced by propranolol.